Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease

Human Molecular Genetics

Volumn 14, Issue 20, 2005, Pages 3065-3078

  Benn, Caroline L ^a,e   Landles, Christian ^a   Li, He ^b   Strand, Andrew D ^c   Woodman, Ben ^a   Sathasivam, Kirupa ^a   Li, Shi Hua ^b   Ghazi Noori, Shabnam ^a   Hockly, Emma ^a   Faruque, Syed M N N ^d   Cha, Jang Ho J ^e   Sharpe, Paul T ^d   Olson, James M ^c   Li, Xiao Jiang ^b   Bates, Gillian P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; MUTANT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN TISSUE; CADAVER; DISEASE COURSE; DNA MICROARRAY; EXON; EXTRACHROMOSOMAL INHERITANCE; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MOUSE; MUTANT; NERVE DEGENERATION; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RNA EXTRACTION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; BRAIN; CELL NUCLEUS; CYTOPLASM; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HUNTINGTON DISEASE; MACROMOLECULAR SUBSTANCES; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NUCLEAR LOCALIZATION SIGNALS; NUCLEAR PROTEINS; PEPTIDES; PHENOTYPE; RNA, MESSENGER; ROTAROD PERFORMANCE TEST; TRANSCRIPTION, GENETIC; TRANSGENES;

ANIMALIA; MUS MUSCULUS;

EID: 27544477225     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi340     Document Type: Article

References (45)

1. Bates, G.P., Harper, P.S. and Jones, A.L. (eds) (2002) Huntington's Disease, 3rd edn. Oxford University Press, Oxford.
2. DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P. and Aronin, N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science, 277, 1990-1993.
3. Becher, M.W., Kotzuk, J.A., Sharp, A.H., Davies, S.W., Bates, G.P., Price, D.L. and Ross, C.A. (1998) Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol. Dis., 4, 387-397.
4. Gutekunst, C.A., Li, S.H., Yi, H., Mulroy, J.S., Kuemmerle, S., Jones, R., Rye, D., Ferrante, R.J., Hersch, S.M. and Li, X.J. (1999) Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology. J. Neurosci., 19, 2522-2534.
5. Bates, G.P. and Benn, C. (2002) The polyglutamine diseases. In Bates, G.P., Harper, P.S. and Jones, A.L. (eds), Huntington's Disease, 3rd edn. Oxford University Press, Oxford, pp. 429-472.
6. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell, 87, 493-506.
7. Carter, R.J., Lione, L.A., Humby, T., Mangiarini, L., Mahal, A., Bates, G.P., Dunnett, S.B. and Morton, A.J. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci., 19, 3248-3257.
8. Lione, L.A., Carter, R.J., Hunt, M.J., Bates, G.P., Morton, A.J. and Dunnett, S.B. (1999) Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J. Neurosci., 19, 10428-10437.
9. DiFiglia, M. (2002) Huntingtin fragments that aggregate go their separate ways. Mol. Cell, 10, 224-225.
10. Petersen, A., Gil, J., Maat-Schieman, M.L., Bjorkqvist, M., Tanila, H., Araujo, I.M., Smith, R., Popovic, N., Wierup, N., Norlen, P. et al. (2005) Orexin loss in Huntington's disease. Hum. Mol. Genet., 14, 39-47.
11. Strand, A.D., Aragaki, A.K., Shaw, D., Bird, T., Holton, J., Turner, C., Tapscott, S.J., Tabrizi, S.J., Schapira, A., Kooperberg, C.L. et al. (2005) Gene expression in Huntington's disease skeletal muscle: A potential biomarker. Hum. Mol. Genet., 14, 1863-1876.
12. Davies, S.W., Turmaine, M., Cozens, B.A., DiFiglia, M., Sharp, A.H., Ross, C.A., Scherzinger, E., Wanker, E.E., Mangiarini, L. and Bates, G.P. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell, 90, 537-548.
13. Li, H., Li, S.H., Cheng, A.L., Mangiarini, L., Bates, G.P. and Li, X.J. (1999) Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. Hum. Mol. Genet., 8, 1227-1236.
14. Saudou, F., Finkbeiner, S., Devys, D. and Greenberg, M.E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell, 95, 55-66.
15. Klement, I.A., Skinner, P.J., Kaytor, M.D., Yi, H., Hersch, S.M., Clark, H.B., Zoghbi, H.Y. and Orr, H.T. (1998) Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice. Cell, 95, 41-53.
16. Katsuno, M., Adachi, H., Kume, A., Li, M., Nakagomi, Y., Niwa, H., Sang, C., Kobayashi, Y., Doyu, M. and Sobue, G. (2002) Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron, 35, 843-854.
17. Jackson, W.S., Tallaksen-Greene, S.J., Albin, R.L. and Detloff, P.J. (2003) Nucleocytoplasmic transport signals affect the age at onset of abnormalities in knock-in mice expressing polyglutamine within an ectopic protein context. Hum. Mol. Genet., 12, 1621-1629.
18. Schilling, G., Savonenko, A.V., Klevytska, A., Morton, J.L., Tucker, S.M., Poirier, M., Gale, A., Chan, N., Gonzales, V., Slunt, H.H. et al. (2004) Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice. Hum. Mol. Genet., 13, 1599-1610.
19. Kalderon, D., Roberts, B.L., Richardson, W.D. and Smith, A.E. (1984) A short amino acid sequence able to specify nuclear location. Cell, 39, 499-509.
20. Fukuda, M., Gotoh, I., Gotoh, Y. and Nishida, E. (1996) Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal. J. Biol. Chem., 271, 20024-20028.
21. Fukuda, M., Gotoh, I., Adachi, M., Gotoh, Y. and Nishida, E. (1997) A novel regulatory mechanism in the mitogen-activated protein (MAP) kinase cascade. Role of nuclear export signal of MAP kinase kinase. J. Biol. Chem., 272, 32642-32648.
22. Rogers, D.C., Fisher, E.M., Brown, S.D., Peters, J., Hunter, A.J. and Martin, J.E. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome, 8, 711-713.
23. Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G.P. and Davies, S.W. (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl Acad. Sci. USA, 97, 8093-8097.
24. Yu, Z.X., Li, S.H., Evans, J., Pillarisetti, A., Li, H. and Li, X.J. (2003) Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. J. Neurosci., 23, 2193-2202.
25. Luthi-Carter, R. and Cha, J.-H.J. (2003) Mechanisms of transcriptional dysregulation in Huntington's disease. Clin. Neurosci. Res., 3, 165-177.
26. Luthi-Carter, R., Hanson, S.A., Strand, A.D., Bergstrom, D.A., Chun, W., Peters, N.L., Woods, A.M., Chan, E.Y., Kooperberg, C., Krainc, D. et al. (2002) Dysregulation of gene expression in the R6/2 model of polyglutamine disease: Parallel changes in muscle and brain. Hum. Mol. Genet., 11, 1911-1926.
27. Luthi-Carter, R., Strand, A.D., Hanson, S.A., Kooperberg, C., Schilling, G., La Spada, A.R., Merry, D.E., Young, A.B., Ross, C.A., Borchelt, D.R. et al. (2002) Polyglutamine and transcription: Gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. Hum. Mol. Genet., 11, 1927-1937.
28. Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B.R., Hayden, M.R., Timmusk, T. et al. (2003) Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet., 35, 76-83.
29. Cornett, J., Cao, F., Wang, C.E., Ross, C.A., Bates, G.P., Li, S.H. and Li, X.J. (2005) Polyglutamine expansion of huntingtin impairs its nuclear export. Nat. Genet., 37, 198-204.
30. Marsh, J.L., Walker, H., Theisen, H., Zhu, Y.Z., Fielder, T., Purcell, J. and Thompson, L.M. (2000) Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum. Mol. Genet., 9, 13-25.
31. Rosas, H.D., Koroshetz, W.J., Chen, Y.I., Skeuse, C., Vangel, M., Cudkowicz, M.E., Caplan, K., Marek, K., Seidman, L.J., Makris, N. et al. (2003) Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis. Neurology, 60, 1615-1620.
32. Fennema-Notestine, C., Archibald, S.L., Jacobson, M.W., Corey-Bloom, J., Paulsen, J.S., Peavy, G.M., Gamst, A.C., Hamilton, J.M., Salmon, D.P. and Jernigan, T.L. (2004) In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology, 63, 989-995.
33. Szebenyi, G., Morfini, G.A., Babcock, A., Gould, M., Selkoe, K., Stenoien, D.L., Young, M., Faber, P.W., MacDonald, M.E., McPhaul, M.J. et al. (2003) Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron, 40, 41-52.
34. Gunawardena, S., Her, L.S., Brusch, R.G., Laymon, R.A., Niesman, I.R., Gordesky-Gold, B., Sintasath, L., Bonini, N.M. and Goldstein, L.S. (2003) Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron, 40, 25-40.
35. Li, H., Li, S.H., Johnston, H., Shelbourne, P.F. and Li, X.J. (2000) Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat. Genet., 25, 385-389.
36. Li, H., Wyman, T., Yu, Z.X., Li, S.H. and Li, X.J. (2003) Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release. Hum. Mol. Genet., 12, 2021-2030.
37. Panov, A.V., Gutekunst, C.A., Leavitt, B.R., Hayden, M.R., Burke, J.R., Strittmatter, W.J. and Greenamyre, J.T. (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci., 5, 731-736.
38. Bezprozvanny, I. and Hayden, M.R. (2004) Deranged neuronal calcium signaling and Huntington disease. Biochem. Biophys. Res. Commun., 322, 1310-1317.
39. Hockly, E., Woodman, B., Mahal, A., Lewis, C.M. and Bates, G. (2003) Standardization and statistical approaches to therapeutic trials in the R6/2 mouse. Brain. Res. Bull., 61, 469-479.
40. Mangiarini, L., Sathasivam, K., Mahal, A., Mott, R., Seller, M. and Bates, G.P. (1997) Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat. Genet., 15, 197-200.
41. Benn, C.L., Farrell, L.A. and Cha, J.H. (2004) Neurotransmitter receptor analysis in transgenic mouse models. Methods Mol. Biol., 277, 231-260.
42. Hallberg, E. (1994) Preparation of nuclei and nuclear envelopes: identification of an integral membrane protein unique to the nuclear envelope. In Celis, J.E. (ed.), Cell Biology: A Laboratory Handbook. Academic Press, San Diego. Vol. 1, pp. 613-627.
43. Sathasivam, K., Woodman, B., Mahal, A., Bertaux, F., Wanker, E.E., Shima, D.T. and Bates, G.P. (2001) Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients. Hum. Mol. Genet., 10, 2425-2435.
44. Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G.P., Davies, S.W., Lehrach, H. and Wanker, E.E. (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell, 90, 549-558.
45. Smith, D.L., Portier, R., Woodman, B., Hockly, E., Mahal, A., Klunk, W.E., Li, X.J., Wanker, E., Murray, K.D. and Bates, G.P. (2001) Inhibition of polyglutamine aggregation in R6/2 HD brain slices-complex dose-response profiles. Neurobiol Dis., 8, 1017-1026.